Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy Medical Devices medical-devices

	Profile	Recent Articles on Subject
1	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	Tarver warns that US device supply chain vulnerabilities could harm patients - 15 days ago FDA finalizes guidance on device shortage reporting rules - 23 days ago FDA warns 2 Chinese labs for oversight failures, animal care violations - 5 months ago FDA’s plan to expand device surveillance faces challenges, GAO finds - 5 months ago FDA sends 2 warning letters after inspecting Chinese syringe manufacturers - 6 months ago FDA creates communication ‘super office’ at CDRH - 7 months ago House committee tells FDA to suspend lab developed test rule - 7 months ago FDA finalizes guidance on studying opioid use disorder treatments - 7 months ago FDA to expand total product life cycle program - 7 months ago FDA expands import alert to block all plastic syringes from Chinese manufacturer - 10 months ago FDA seeks feedback on expansion of premarket cybersecurity guidance - 11 months ago FDA warns industry of ‘fraudulent’ third-party data in device applications - 12 months ago FDA authorizes record number of new devices in 2023 - about 1 year ago FDA acts on industry call for clarity about scope of device shortage reporting rules - about 1 year ago Acon receives first FDA clearance for over-the-counter COVID-19 antigen test - about 1 year ago FDA finalizes COVID-era guidance, extending flexibility for some remote monitoring devices - over 1 year ago FDA expands total product life cycle program to cover neurological devices - over 1 year ago FDA shares draft medical device harmonization plan to meet MDUFA V goal - over 1 year ago FDA releases draft guidance for studying weight loss devices - over 1 year ago FDA finalizes breakthrough device changes to target health inequities - over 1 year ago House committee tells FDA to suspend lab developed test rule - 7 months ago
2	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	FDA ‘stuck to its corner’ with AI draft guidance, leaving plenty of questions unanswered - 19 days ago FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage - 3 months ago 3 FDA approval dates to watch in the year’s final push - 5 months ago FDA’s platform designation aims to ease R&D pain points - 8 months ago After ‘tragic’ bacterial outbreak, lawmakers press FDA to step up foreign inspections - 11 months ago FDA inches closer to defining its regulatory role in AI - 12 months ago
3	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about FDA commish’s parting thoughts, a warning on RSV shots, and more - 23 days ago STAT+: Pharmalittle: We’re reading about FDA guidance on AI, meds releasing ‘forever chemicals,’ and more - 24 days ago STAT+: Pharmalittle: We’re reading about picking an FDA chief, a menopause film controversy, and more - 2 months ago STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 3 months ago STAT+: FDA agrees to review a rare disease drug that its developer was about to give up on - 10 months ago STAT+: FDA is still struggling to inspect clinical research sites, watchdog finds - 10 months ago STAT+: FDA gives a mixed response to a petition seeking greater clinical trial transparency - 11 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - about 1 year ago STAT+: FDA is blasted by advocates for pursuing a deal with data provider that has ties to opioid makers - about 1 year ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - about 1 year ago STAT+: In response to criticism, FDA publishes new database of wayward clinical trial sponsors - about 1 year ago STAT+: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices - about 1 year ago STAT+: FDA efforts to oversee foreign drug manufacturing remain inadequate to ensure safety, analysis finds - about 1 year ago STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs - about 1 year ago STAT+: More drug and device patents were invalidated for bad info than those filed by other industries, analysis finds - about 1 year ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - about 1 year ago STAT+: Pharmalittle: Pharma trade group slams European Commission proposal; U.S. lawmakers demand FDA explain its approach to shortages - about 1 year ago STAT+: Pharmalittle: FDA panel lacks confidence in Amgen cancer drug data; weight loss drugs linked to rare stomach problems - over 1 year ago
4	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: 3 key issues to watch at the FDA as Trump takes office - about 1 month ago STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 3 months ago STAT+: Another suit filed against FDA over lab-developed test rule - 6 months ago STAT+: FDA warns medical device makers about rise in fabricated data - 12 months ago
5	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 3 months ago STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound - 12 months ago
6	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 5 months ago
7	Brittany Trang STAT News Health care business reporter. PhD. Indie rock fan. health carebusiness reporting	STAT+: ‘Sarepta’s like a curse on me’: FDA commissioner dismisses controversy over Elevidys - 5 months ago
8	Adam Spatacco Motley Fool Community for top investors. Investingcommunity	This Is Massive News for Eli Lilly Investors - 7 months ago
9	Joyce Frieden MedPage Today Washington editor at MedPage Today. Board member at AHCJ. Greater Washington, DC area Healthcare journalism	House Committee Wrestles With Lab Test Regulation - 11 months ago FDA Approves Florida's Proposal to Import Prescription Drugs From Canada - about 1 year ago
10	Damian Garde STAT News Biotech reporter at STAT. Open to messages. biotechnologyjournalism	The FDA isn’t afraid to yank a disappointing drug - 11 months ago

Journalists covering FDA